trending Market Intelligence /marketintelligence/en/news-insights/trending/sIa0Y399MW5ysgAviY2sFw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Fresenius Medical to buy back up to €330M of shares

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Fresenius Medical to buy back up to €330M of shares

Fresenius Medical Care AG & Co. KGaA is planning to buy back up to €330 million worth of ordinary shares as part of a share repurchase program.

The German maker of kidney dialysis products will buy back up to a maximum of 6 million ordinary shares, representing about 1.6% of Fresenius' share capital. The repurchased shares will be used to reduce the registered share capital, which will be done by canceling the shares that are bought back by the company.

Fresenius said the repurchases will take place March 12-May 10, noting that the share buyback program may be suspended or restarted at any time.